Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting

BACKGROUND: KRAS mutations occur frequently in advanced non-small cell lung cancer (aNSCLC); the G12C mutation is the most prevalent. Alterations in STK11 or KEAP1 commonly co-occur with KRAS mutations in aNSCLC. Using real-world data, we assessed the effect of KRAS G12C mutation with or without STK...

Descripción completa

Detalles Bibliográficos
Autores principales: Julian, Cristina, Pal, Navdeep, Gershon, Anda, Evangelista, Marie, Purkey, Hans, Lambert, Peter, Shi, Zhen, Zhang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108521/
https://www.ncbi.nlm.nih.gov/pubmed/37069542
http://dx.doi.org/10.1186/s12885-023-10778-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108521/
https://www.ncbi.nlm.nih.gov/pubmed/37069542
http://dx.doi.org/10.1186/s12885-023-10778-6

Ejemplares similares